Confirming this hypothesis, thalidomide given to prostate cancer patients prior to surgery resulted in reduced microvessel density as well as decreased expression of VEGF and IL-6 in prostatectomy specimens [42]. The gene discussed is VEGFA; the disease is prostate carcinoma.